Industry
Biotechnology
Tevogen Bio Holdings Inc. operates as a clinical-stage biotechnology company that develops off-the-shelf precision T cell therapeutics in virology, oncology, and neurology. Its lead investigational precision T cell product, TVGN 489, is designed to address the unmet need of acute-risk COVID-19 patients, as well as a subset of patients suffering from long COVID. The company is based in Warren, New Jersey.
Loading...
Open
N/A
Mkt cap
N/A
Volume
N/A
High
N/A
P/E Ratio
N/A
52-wk high
N/A
Low
N/A
Div yield
N/A
52-wk low
N/A
Portfolio Pulse from Benzinga Insights
June 06, 2024 | 8:31 pm
Portfolio Pulse from Benzinga Newsdesk
June 06, 2024 | 7:54 pm
Portfolio Pulse from Benzinga Newsdesk
May 29, 2024 | 12:11 pm
Portfolio Pulse from Benzinga Insights
May 21, 2024 | 12:06 pm
Portfolio Pulse from Avi Kapoor
May 13, 2024 | 5:01 pm
Portfolio Pulse from ryanfaloona@benzinga.com
May 13, 2024 | 12:42 pm
Portfolio Pulse from Benzinga Insights
May 13, 2024 | 12:06 pm
Portfolio Pulse from Avi Kapoor
May 13, 2024 | 9:46 am
Portfolio Pulse from Avi Kapoor
May 07, 2024 | 11:18 am
All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.